Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Revicki, DA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 70 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Frank, L; Revicki, DA; Sorensen, SV; Shih, YCT
      The economics of selective serotonin reuptake inhibitors in depression - Acritical review

      CNS DRUGS
    2. Rentz, AM; Battista, C; Trudeau, E; Jones, R; Robinson, P; Sloan, S; Mathur, S; Frank, L; Revicki, DA
      Symptom and health-related quality-of-life measures for use in selected gastrointestinal disease studies - A review and synthesis of the literature

      PHARMACOECONOMICS
    3. Revicki, DA; Gold, K; Buckman, D; Chan, K; Kallich, JD; Woolley, JM
      Imputing physical health status scores missing owing to mortality - Results of a simulation comparing multiple techniques

      MEDICAL CARE
    4. Mavissakalian, MR; Schmier, JK; Flynn, JA; Revicki, DA
      Cost effectiveness of acute imipramine therapy versus two imipramine maintenance treatment regimens for panic disorder

      PHARMACOECONOMICS
    5. Kaplan-Machlis, B; Spiegler, GE; Zodet, MW; Revicki, DA
      Effectiveness and costs of omeprazole vs ranitidine for treatment of symptomatic gastroesophageal reflux disease in primary care clinics in West Virginia

      ARCHIVES OF FAMILY MEDICINE
    6. Revicki, DA; Osoba, D; Fairclough, D; Barofsky, I; Berzon, R; Leidy, NK; Rothman, M
      Recommendations on health-related quality of life research to support labeling and promotional claims in the United States

      QUALITY OF LIFE RESEARCH
    7. Hamilton, SH; Edgell, ET; Revicki, DA; Breier, A
      Functional outcomes in schizophrenia: a comparison of olanzapine and haloperidol in a European sample

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    8. Revicki, DA; Swartz, C; Wu, AW; Haubrich, R; Collier, AC
      Quality of life outcomes of saquinavir, zalcitabine and combination saquinavir plus zalcitabine therapy for adults with advanced HIV infection with CD4 counts between 50 and 300 cells/mm(3)

      ANTIVIRAL THERAPY
    9. Revicki, DA; Frank, L
      Pharmacoeconomic evaluation in the real world - Effectiveness versus efficacy studies

      PHARMACOECONOMICS
    10. Hamilton, SH; Revicki, DA; Edgell, ET; Genduso, LA; Genduso, LA; Tollefson, G
      Clinical and economic outcomes of olanzapine compared with haloperidol forschizophrenia - Results from a randomised clinical trial

      PHARMACOECONOMICS
    11. Kaplan-Machlis, B; Spiegler, GE; Revicki, DA
      Health-related quality of life in primary care patients with gastroesophageal reflux disease

      ANNALS OF PHARMACOTHERAPY
    12. Revicki, DA; Genduso, LA; Hamilton, SH; Ganoczy, D; Beasley, CM
      Olanzapine versus haloperidol in the treatment of schizophrenia and other psychotic disorders: Quality of life and clinical outcomes of a randomized clinical trial

      QUALITY OF LIFE RESEARCH
    13. Revicki, DA
      Pharmacoeconomic studies of atypical antipsychotic drugs for the treatmentof schizophrenia

      SCHIZOPHRENIA RESEARCH
    14. Revicki, DA; Moyle, G; Stellbrink, HJ; Barker, C
      Quality of life outcomes of combination zalcitabine-zidovudine, saquinavir-zidovudine, and saquinavir-zalcitabine-zidovudine therapy for HIV-infectedadults with CD4 cell counts between 50 and 350 per cubic millimeter

      AIDS
    15. Revicki, DA; Crawley, JA; Zodet, MW; Levine, DS; Joelsson, BO
      Complete resolution of heartburn symptoms and health-related quality of life in patients with gastro-oesophageal reflux disease

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    16. Revicki, DA
      Pharmacoeconomic evaluation of treatments for refractory schizophrenia: Clozapine-related studies

      JOURNAL OF CLINICAL PSYCHIATRY
    17. PALMER CS; KLEINMAN L; TAYLOR LA; REVICKI DA
      PHARMACOECONOMICS OF ANTIDEPRESSANT DRUG OVERDOSE

      CNS drugs
    18. REVICKI DA; PALMER C
      UNTITLED - AUTHORS REPLY

      American journal of managed care
    19. PALMER CS; REVICKI DA; GENDUSO LA; HAMILTON SH; BROWN RE
      A COST-EFFECTIVENESS CLINICAL DECISION-ANALYSIS MODEL FOR SCHIZOPHRENIA

      American journal of managed care
    20. REVICKI DA; CHAN K; GEVIRTZ F
      DISCRIMINANT VALIDITY OF THE MEDICAL-OUTCOMES-STUDY COGNITIVE FUNCTION SCALE IN HIV DISEASE PATIENTS

      Quality of life research
    21. BARTMAN BA; ROSEN MJ; BRADHAM DD; WEISSMAN J; HOCHBERG M; REVICKI DA
      RELATIONSHIP BETWEEN HEALTH-STATUS AND UTILITY MEASURES IN OLDER CLAUDICANTS

      Quality of life research
    22. REVICKI DA; WOOD M; WIKLUND I; CRAWLEY J
      RELIABILITY AND VALIDITY OF THE GASTROINTESTINAL SYMPTOM RATING-SCALEIN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE

      Quality of life research
    23. Revicki, DA; Leidy, NK; Brennan-Diemer, F; Thompson, C; Togias, A
      Development and preliminary validation of the multiattribute rhinitis symptom utility index

      QUALITY OF LIFE RESEARCH
    24. HAMILTON SH; GENDUSO LA; REVICKI DA
      MEDICAL RESOURCE USE AND WORK AND SOCIAL OUTCOMES FOR OLANZAPINE COMPARED WITH HALOPERIDOL IN THE TREATMENT OF SCHIZOPHRENIA AND OTHER PSYCHOTIC DISORDERS

      Schizophrenia research
    25. HAMILTON SH; REVICKI DA; GENDUSO LA; TOLLEFSON GD
      COSTS OF OLANZAPINE TREATMENT COMPARED WITH HALOPERIDOL FOR SCHIZOPHRENIA - RESULTS FROM A RANDOMIZED CLINICAL-TRIAL

      Schizophrenia research
    26. HAMILTON SH; REVICKI DA; GENDUSO LA; BEASLEY CM
      OLANZAPINE VERSUS PLACEBO AND HALOPERIDOL - QUALITY-OF-LIFE AND EFFICACY RESULTS OF THE NORTH-AMERICAN DOUBLE-BLIND TRIAL

      Neuropsychopharmacology
    27. COHEN C; REVICKI DA; NABULSI A; SAROCCO PW; JIANG P
      A RANDOMIZED TRIAL OF THE EFFECT OF RITONAVIR IN MAINTAINING QUALITY-OF-LIFE IN ADVANCED HIV DISEASE

      AIDS
    28. Revicki, DA; Sorensen, S; Maton, PN; Orlando, RC
      Health-related quality of life outcomes of omeprazole versus ranitidine inpoorly responsive symptomatic gastroesophageal reflux disease

      DIGESTIVE DISEASES
    29. LEIDY NK; PALMER C; MURRAY M; ROBB J; REVICKI DA
      HEALTH-RELATED QUALITY-OF-LIFE ASSESSMENT IN EUTHYMIC AND DEPRESSED-PATIENTS WITH BIPOLAR DISORDER - PSYCHOMETRIC PERFORMANCE OF 4 SELF-REPORT MEASURES

      Journal of affective disorders
    30. REVICKI DA; WOOD M
      PATIENT-ASSIGNED HEALTH STATE UTILITIES FOR DEPRESSION-RELATED OUTCOMES - DIFFERENCES BY DEPRESSION SEVERITY AND ANTIDEPRESSANT MEDICATIONS

      Journal of affective disorders
    31. CHAN KS; REVICKI DA
      CHANGES IN SURROGATE LABORATORY MARKERS, CLINICAL END-POINTS, AND HEALTH-RELATED QUALITY-OF-LIFE IN PATIENTS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS

      Evaluation & the health professions
    32. Revicki, DA; Simon, GE; Chan, K; Katon, W; Heiligenstein, J
      Depression, health-related quality of life, and medical cost outcomes of receiving recommended levels of antidepressant treatment

      JOURNAL OF FAMILY PRACTICE
    33. SIMON GE; REVICKI DA; GROTHAUS L; VONKORFF M
      SF-36 SUMMARY SCORES - ARE PHYSICAL AND MENTAL-HEALTH TRULY DISTINCT

      Medical care
    34. REVICKI DA; SORENSEN S; WU AW
      RELIABILITY AND VALIDITY OF PHYSICAL AND MENTAL-HEALTH SUMMARY SCORESFROM THE MEDICAL OUTCOMES STUDY HIV HEALTH SURVEY

      Medical care
    35. REVICKI DA; LEIDY NK; BRENNANDIEMER F; SORENSEN S; TOGIAS A
      INTEGRATING PATIENT PREFERENCES INTO HEALTH OUTCOMES ASSESSMENT - THEMULTIATTRIBUTE ASTHMA SYMPTOM UTILITY INDEX

      Chest
    36. REVICKI DA; WOOD M; MATON PN; SORENSEN S
      THE IMPACT OF GASTROESOPHAGEAL REFLUX DISEASE ON HEALTH-RELATED QUALITY-OF-LIFE

      The American journal of medicine
    37. REVICKI DA
      METHODS OF PHARMACOECONOMIC EVALUATION OF PSYCHOPHARMACOLOGICAL THERAPIES FOR PATIENTS WITH SCHIZOPHRENIA

      Journal of psychiatry & neuroscience
    38. REVICKI DA; PALMER CS; PHILLIPS SD; REBLANDO JA; HEILIGENSTEIN JH; BRENT J; KULIG K
      ACUTE MEDICAL COSTS OF FLUOXETINE VERSUS TRICYCLIC ANTIDEPRESSANTS - A PROSPECTIVE MULTICENTER STUDY OF ANTIDEPRESSANT DRUG OVERDOSES

      PharmacoEconomics
    39. REVICKI DA; TOHEN M; GYULAI L; THOMPSON C; PIKE S; DAVISVOGEL A; ZARATE C
      TELEPHONE VERSUS IN-PERSON CLINICAL AND HEALTH-STATUS ASSESSMENT INTERVIEWS IN PATIENTS WITH BIPOLAR DISORDER

      Harvard review of psychiatry
    40. WU AW; REVICKI DA; JACOBSON D; MALITZ FE
      EVIDENCE FOR RELIABILITY, VALIDITY AND USEFULNESS OF THE MEDICAL OUTCOMES STUDY HIV HEALTH SURVEY (MOS-HIV)

      Quality of life research
    41. REVICKI DA; CELLA DF
      HEALTH-STATUS ASSESSMENT FOR THE 21ST-CENTURY - ITEM RESPONSE THEORY,ITEM BANKING AND COMPUTER ADAPTIVE TESTING

      Quality of life research
    42. WU AW; JACOBSON DL; BERZON RA; REVICKI DA; VANDERHORST C; FICHTENBAUM CJ; SAAG MS; LYNN L; HARDY D; FEINBERG J
      THE EFFECT OF MODE OF ADMINISTRATION ON MEDICAL OUTCOMES STUDY HEALTHRATINGS AND EUROQOL SCORES IN AIDS

      Quality of life research
    43. REVICKI DA; BROWN RE; KELLER MB; GONZALES J; CULPEPPER L; HALES RE
      COST-EFFECTIVENESS OF NEWER ANTIDEPRESSANTS COMPARED WITH TRICYCLIC ANTIDEPRESSANTS IN MANAGED CARE SETTINGS

      The Journal of clinical psychiatry
    44. REVICKI DA; EHRETH JL
      HEALTH-RELATED QUALITY-OF-LIFE ASSESSMENT AND PLANNING FOR THE PHARMACEUTICAL-INDUSTRY

      Clinical therapeutics
    45. REVICKI DA; SORENSEN S; WOOD M
      RELIABILITY AND VALIDITY OF THE GASTROINTESTINAL SYMPTOM RATING-SCALEIN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE

      Gastroenterology
    46. REVICKI DA; LEIDY NK; HOWLAND L
      EVALUATING THE PSYCHOMETRIC CHARACTERISTICS OF THE PSYCHOLOGICAL GENERAL WELL-BEING INDEX WITH A NEW RESPONSE SCALE

      Quality of life research
    47. REVICKI DA; SHAKESPEARE A; KIND P
      PREFERENCES FOR SCHIZOPHRENIA-RELATED HEALTH STATES - A COMPARISON OFPATIENTS, CAREGIVERS AND PSYCHIATRISTS

      International clinical psychopharmacology
    48. SIMON GE; VONKORFF M; HEILIGENSTEIN JH; REVICKI DA; GROTHAUS L; KATON W; WAGNER EH
      INITIAL ANTIDEPRESSANT CHOICE IN PRIMARY-CARE - EFFECTIVENESS AND COST OF FLUOXETINE VS TRICYCLIC ANTIDEPRESSANTS

      JAMA, the journal of the American Medical Association
    49. REVICKI DA; BROWN RE; PALMER W; BAKISH D; ROSSER WW; ANTON SF; FEENY D
      MODELING THE COST-EFFECTIVENESS OF ANTIDEPRESSANT TREATMENT IN PRIMARY-CARE

      PharmacoEconomics
    50. REVICKI DA; SIMPSON KN; WU AW; LAVALLEE RL
      EVALUATING THE QUALITY-OF-LIFE ASSOCIATED WITH RIFABUTIN PROPHYLAXIS FOR MYCOBACTERIUM-AVIUM COMPLEX IN PERSONS WITH AIDS - COMBINING Q-TWIST AND MULTIATTRIBUTE UTILITY TECHNIQUES

      Quality of life research
    51. PALMER CS; REVICKI DA; HALPERN MT; HATZIANDREU EJ
      THE COST OF SUICIDE AND SUICIDE ATTEMPTS IN THE UNITED-STATES

      Clinical neuropharmacology
    52. REVICKI DA; BROWN RE; FEENY DH; HENRY D; TEEHAN BP; RUDNICK MR; BENZ RL
      HEALTH-RELATED QUALITY-OF-LIFE ASSOCIATED WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY FOR PREDIALYSIS CHRONIC RENAL-DISEASE PATIENTS

      American journal of kidney diseases
    53. ANTON SF; REVICKI DA
      THE USE OF DECISION-ANALYSIS IN THE PHARMACOECONOMIC EVALUATION OF ANANTIDEPRESSANT - A COST-EFFECTIVENESS STUDY OF NEFAZODONE

      Psychopharmacology bulletin
    54. REVICKI DA; LUCE BR
      METHODS OF PHARMACOECONOMIC EVALUATION OF NEW MEDICAL TREATMENTS IN PSYCHIATRY

      Psychopharmacology bulletin
    55. REVICKI DA; WU AW; MURRAY MI
      CHANGE IN CLINICAL STATUS, HEALTH-STATUS, AND HEALTH UTILITY OUTCOMESIN HIV-INFECTED PATIENTS

      Medical care
    56. REVICKI DA; MURRAY M
      ASSESSING HEALTH-RELATED QUALITY-OF-LIFE OUTCOMES OF DRUG TREATMENTS FOR PSYCHIATRIC-DISORDERS

      CNS DRUGS
    57. HATZIANDREU EJ; BROWN RE; REVICKI DA; TURNER R; MARTINDALE J; LEVINE S; SIEGEL JE
      COST-UTILITY OF MAINTENANCE TREATMENT OF RECURRENT DEPRESSION WITH SERTRALINE VERSUS EPISODIC TREATMENT WITH DOTHIEPIN

      PharmacoEconomics
    58. REVICKI DA; SIMPSON KN; WU AW; LAVALLEE RL
      QUALITY-OF-LIFE IN RIFABUTIN PROPHYLAXIS FOR MYCOBACTERIUM-AVIUM COMPLEX IN PEOPLE WITH AIDS

      Quality of life research
    59. WU AW; JACOBSON DL; REVICKI DA; FEINBERG JE; BERZON RA
      THE EFFECT OF MODE OF ADMINISTRATION AND NUMBER OF RESPONSE CATEGORIES ON MEDICAL OUTCOMES STUDY HEALTH RATINGS AND EUROQOL SCORES IN PEOPLE WITH AIDS

      Quality of life research
    60. REVICKI DA; ALLEN H; BUNGAY K; WILLIAMS GH; WEINSTEIN MC
      RESPONSIVENESS AND CALIBRATION OF THE GENERAL WELL-BEING ADJUSTMENT SCALE IN PATIENTS WITH HYPERTENSION

      Journal of clinical epidemiology
    61. REVICKI DA; BROWN RE; HENRY DH; MCNEILL MV; RIOS A; WATSON T
      RECOMBINANT-HUMAN-ERYTHROPOIETIN AND HEALTH-RELATED QUALITY-OF-LIFE OF AIDS PATIENTS WITH ANEMIA

      Journal of acquired immune deficiency syndromes
    62. ROTH D; SMITH RD; SCHULMAN G; STEINMAN TI; HATCH FE; RUDNICK MR; SLOAND JA; FREEDMAN BI; WILLIAMS WW; SHADUR CA; BENZ RL; TEEHAN BP; REVICKI DA; SAROKHAN BJ; ABELS RI
      EFFECTS OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ON RENAL-FUNCTION IN CHRONIC-RENAL-FAILURE PREDIALYSIS PATIENTS

      American journal of kidney diseases
    63. WHITLEY TW; ALLISON EJ; GALLERY ME; COCKINGTON RA; GAUDRY P; HEYWORTH J; REVICKI DA
      WORK-RELATED STRESS AND DEPRESSION AMONG PRACTICING EMERGENCY PHYSICIANS - AN INTERNATIONAL STUDY

      Annals of emergency medicine
    64. REVICKI DA; IRWIN D; REBLANDO J; SIMON GE
      THE ACCURACY OF SELF-REPORTED DISABILITY DAYS

      Medical care
    65. REVICKI DA; WHITLEY TW; GALLERY ME; ALLISON EJ
      IMPACT OF WORK-ENVIRONMENT CHARACTERISTICS ON WORK-RELATED STRESS ANDDEPRESSION IN EMERGENCY-MEDICINE RESIDENTS - A LONGITUDINAL-STUDY

      Journal of community & applied social psychology
    66. KAPLAN RM; FEENY D; REVICKI DA
      METHODS FOR ASSESSING RELATIVE IMPORTANCE IN PREFERENCE BASED OUTCOMEMEASURES

      Quality of life research
    67. REVICKI DA; KAPLAN RM
      RELATIONSHIP BETWEEN PSYCHOMETRIC AND UTILITY-BASED APPROACHES TO THEMEASUREMENT OF HEALTH-RELATED QUALITY-OF-LIFE

      Quality of life research
    68. REVICKI DA; WHITLEY TW; GALLERY ME
      ORGANIZATIONAL CHARACTERISTICS, PERCEIVED WORK STRESS, AND DEPRESSIONIN EMERGENCY-MEDICINE RESIDENTS

      Behavioral medicine
    69. HEYWORTH J; WHITLEY TW; ALLISON EJ; REVICKI DA
      CORRELATES OF WORK-RELATED STRESS AMONG CONSULTANTS AND SENIOR REGISTRARS IN ACCIDENT AND EMERGENCY-MEDICINE

      Archives of emergency medicine
    70. HEYWORTH J; WHITLEY TW; ALLISON EJ; REVICKI DA
      PREDICTORS OF WORK SATISFACTION AMONG SHOS DURING ACCIDENT AND EMERGENCY-MEDICINE TRAINING

      Archives of emergency medicine


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 07/06/20 alle ore 12:21:32